AEM vs CX

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

CX presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but non-improving financial health. While the company shows strong top-line revenue growth (10.10% YoY) and an extremely attractive PEG ratio of 0.39, these are offset by a severe collapse in earnings growth (-66.40% YoY). Liquidity is a primary concern with a current ratio of 0.86 and a quick ratio of 0.55, suggesting potential short-term obligations pressure. Despite a bullish analyst consensus and strong 1-year price performance, the provided technical trend score of 10/100 suggests a bearish shift in momentum.